Mamta Puraswani Selected Research

Lipoid Nephrosis (Glomerulonephritis, Minimal Change)

3/2014

Serum-soluble urokinase receptor levels do not distinguish focal segmental glomerulosclerosis from other causes of nephrotic syndrome in children.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mamta Puraswani Research Topics

Disease

5	Atypical Hemolytic Uremic Syndrome 01/2024 - 04/2018
3	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2019 - 03/2014
2	Hemolytic-Uremic Syndrome 01/2024 - 04/2018
2	Genetic Predisposition to Disease (Genetic Predisposition) 06/2018 - 02/2018
1	Infections 12/2023
1	Mucormycosis 12/2022
1	Bacterial Infections (Bacterial Infection) 12/2022
1	Coinfection 12/2022
1	Proteinuria 03/2014
1	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 03/2014
1	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 03/2014

Drug/Important Bio-Agent (IBA)

3	Complement Factor H (Factor H)IBA 01/2024 - 01/2019
2	Complement System Proteins (Complement)IBA 01/2023 - 06/2018
2	AutoantibodiesIBA 01/2023 - 02/2018
1	eculizumab FDA Link 01/2024
1	Colistin (Coly-Mycin)FDA Link 12/2023
1	ProcalcitoninIBA 12/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019
1	Levamisole (Decaris)FDA Link 01/2019
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2019
1	Rituximab (Mabthera)FDA Link 10/2018
1	Monoclonal AntibodiesIBA 10/2018
1	Membrane Cofactor ProteinIBA 04/2018
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 03/2014
1	CreatinineIBA 03/2014
1	SteroidsIBA 03/2014

Therapy/Procedure

2	Plasma Exchange 01/2024 - 04/2018
2	Therapeutics 01/2023 - 01/2019
1	Length of Stay 12/2022